Jolomi Ikomi, M.D.

Our Experts

Back to all Experts
Jolomi Ikomi, M.D.

Jolomi Ikomi, M.D.

Medical Director of Project Recovery

Expertise & Research Interests

  • Addiction Treatment
  • Substance Use Disorders
  • Addiction and mental health counseling

Education

  • Medical Degree, University of Ibadan Medical School

Jolomi Ikomi, M.D.

Medical Director of Project Recovery

Dr. Jolomi Ikomi is board-certified addiction psychiatrist who specializes in the treatment of dual diagnosis disorders (that is treatment of a combination of substance use disorders and mental illness).

He joined ChristianaCare with eight years of clinical and leadership experience in addiction psychiatry as a staff psychiatrist and medical director, most recently at a clinic where he helped establish and develop an outpatient addiction treatment program, and previously with substance abuse treatment unit (SATU) which is a Yale university affiliated dual diagnosis outpatient clinic where he was the medical director. He has held academic positions as an assistant professor of psychiatry at both Yale University and University of Cincinnati.

Dr. Ikomi has contributed to books and articles published in peer-reviewed journals, presented at conferences and served on committees for clinical excellence, addiction treatment expansion, education, and utilization and management review.

Experience

Media Appearances

ChristianaCare turns to Pear digital therapeutics in addiction treatment.

2020-11-17 , Delaware Business Now
Patients in Delaware and surrounding communities seeking treatment for opioid and substance use disorders will now have access to a treatment option, prescription digital therapeutics (PDTs), thanks to a collaboration between ChristianaCare and Pear Therapeutics, Inc. “The Covid-19 pandemic has highlighted the vital importance of connecting people with the substance-use disorder to effective therapies, and ensuring that they have access to these therapies when and where they need it,” said Jolomi Ikomi, M.D., medical director of Project Recovery at ChristianaCare. “FDA-authorized prescription digital therapeutics used with complementary therapy is shown to keep patients on the path to recovery. The use of proven software-based therapeutics could provide innovative, convenient, and cost-effective care to assist in the fight against addiction.”

Delaware Public Media World Cafe Providers say drug and alcohol use up during pandemic following record year of Delaware overdoses

2020-06-21 , Delaware Public Media
Dr. Jolomi Ikomi is Medical Director of Project Recovery at ChristianaCare. He says it’s still too early to draw conclusions from the available data around an increase in overdoses, but adds the increase in relapse during the pandemic has been noticeable. “More patients are struggling, and mainly as a result of things like there’s lack of social support. There is more isolation,” said Ikomi. “Dual diagnosis of drug addiction and mental illness is a disease where we ask patients to get more support and engage more in treatment and they’re finding that difficult.”
External Service and Affiliations
  • American Board of Psychiatry and Neurology
  • American Academy of Addiction Psychiatry